by admin | Apr 28, 2025 | News & Opinions
By Nippon.com – Japan is a global leader in cutting-edge research into the use of iPS cells, whose potentials include the development of revolutionary new medicines and treatments for incurable diseases. We sat down with Etō Kōji, the deputy director of Kyoto...
by admin | Apr 25, 2025 | News & Opinions
By Cedars Sinai – Board of Governors Regenerative Medicine Institute Looks to the Future With Three New Leadership Appointments, Master’s Program The Cedars-Sinai Board of Governors Regenerative Medicine Institute is marking its 15th anniversary by further...
by admin | Apr 24, 2025 | News & Opinions
By CNN – The hunt for cancer-combatting antibodies normally relies upon human lab scientists combing through vast amounts of data. LabGenius’ automated AI robotic system has disrupted that process. Using machine learning, their model has pushed through the human...
by admin | Apr 24, 2025 | News & Opinions
By Jonathan D. Grinstein, PhD – Inside Precision Medicine – BlueRock Therapeutics and Kyoto University showed transplants of lab-grown dopamine neurons are safe, with potential to advance Parkinson’s treatment Two independent teams of researchers...
by admin | Apr 22, 2025 | News & Opinions
By News Medical Life Sciences – Bone regeneration continues to be a critical challenge in tissue engineering, with unpredictable outcomes often hindering clinical application. Current strategies overlook key factors such as donor differences and biological sex,...
by admin | Apr 21, 2025 | News & Opinions
by Kadeja Johnson – RegMedNet – 4basebio PLC has received a Good Manufacturing Practice certification from the UK Medicine and Healthcare Regulatory Agency (London), authorizing the company to supply GMP-grade synthetic DNA as both a starting material and...
